NFE2L2 and lung carcinoma: Additionally, an innovative NRF2 nano-modulator has demonstrated its ability to induce ferroptosis in lung cancer, leading to a shift in M2 macrophage polarization towards M1 and enhancing anti-tumor immunity [59].